Zobrazeno 1 - 10
of 67
pro vyhledávání: '"Constanze Rémi"'
Autor:
Farina Hodiamont, Caroline Schatz, Eva Schildmann, Zulfiya Syunyaeva, Katerina Hriskova, Constanze Rémi, Reiner Leidl, Susanne Tänzler, Claudia Bausewein
Publikováno v:
BMC Palliative Care, Vol 22, Iss 1, Pp 1-11 (2023)
Abstract Background The COVID-19 pandemic impacts on working routines and workload of palliative care (PC) teams but information is lacking how resource use and associated hospital costs for PC changed at patient-level during the pandemic. We aim to
Externí odkaz:
https://doaj.org/article/4e1c2568765749c297d36fab0728411f
Publikováno v:
Pharmacy, Vol 11, Iss 5, p 160 (2023)
Pharmacotherapy plays a crucial role in symptom management in palliative care and is associated with risks potentially leading to drug-related problems (DRP). Pharmacists can identify DRPs and advise prescribers on optimizing drug therapy. The aim of
Externí odkaz:
https://doaj.org/article/5226665f727448c8a39adfbe4852f8f2
Autor:
Farina Hodiamont, Caroline Schatz, Eva Schildmann, Zulfiya Syunyaeva, Katerina Hriskova, Constanze Rémi, Reiner Leidl, Susanne Tänzler, Claudia Bausewein
Publikováno v:
BMC Palliative Care, Vol 22, Iss 1, Pp 1-1 (2023)
Externí odkaz:
https://doaj.org/article/be168889b4954e829174594de902ab73
Publikováno v:
Onkologie up2date. :215-220
Sedation in palliative care, also called "palliative sedation", is an important treatment option for patients who experience unbearable suffering from treatment-refractory symptoms at the end of life. The aim is to reduce this suffering as far as pos
Autor:
Sonja Gauder, Anne Pralong, Constanze Rémi, Farina Hodiamont, Isabell Klinger, Maria Heckel, Steffen T Simon, Claudia Bausewein
Publikováno v:
Palliative Medicine. 36:1285-1295
Background: The SARS-CoV-2 pandemic is a constant challenge for health care systems, also in Germany. Care of seriously ill and dying people and their relatives is often neglected and suffering increased due to sub-optimal symptom management, visitin
Publikováno v:
International Journal of Clinical Pharmacy.
Off-label drug use is common practice in palliative care. It may pose a risk to the patient and benefit should outweigh harm. A decision and documentation aid for off-label use was developed to support practitioners in clinical practice off-label use
Publikováno v:
Laryngo-Rhino-Otologie.
ZusammenfassungDie medizinische Verwendung von Cannabis hat in den letzten Jahren in Europa und Nordamerika an Popularität gewonnen. Cannabinoide sind sowohl als Fertigarzneimittel als auch in Blüten- und Extraktform verfügbar. Der vorliegende Art
Publikováno v:
Zeitschrift für Palliativmedizin. 22:255-264
Publikováno v:
Deutsche medizinische Wochenschrift (1946). 147(14)
The medical use of Cannabis has gained popularity in Europe and Northern America in recent years. Cannabinoids are available as finished pharmaceuticals, flowers and extracts. This article focuses on supportive medicine for oncological patients. Poss
Publikováno v:
European Journal of Hospital Pharmacy. 29:329-335
Objective Off-label drug use seems to be integral to adult palliative care pharmacotherapy. Balancing potential risks and benefits in the context of limited therapeutic options is challenging. To provide specific support for clinicians in dealing wit